Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Valeritas Holdings Inc. (VLRX)

1.48   -0.01 (-0.67%) 11-19 16:00
Open: 1.45 Pre. Close: 1.49
High: 1.5 Low: 1.45
Volume: 39,508 Market Cap: 12M
Valeritas Holdings Inc is a commercial-stage medical technology company. It is engaged in the business of improving health and simplifying life for diabetic patients by developing and commercializing innovative technologies.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.503 - 1.511 1.511 - 1.521
Low: 1.426 - 1.436 1.436 - 1.446
Close: 1.462 - 1.479 1.479 - 1.497

Technical analysis

as of: 2019-11-19 4:30:53 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.89     One year: 2.21
Support: Support1: 1.37    Support2: 1.21
Resistance: Resistance1: 1.62    Resistance2: 1.89
Pivot: 1.48
Moving Average: MA(5): 1.48     MA(20): 1.45
MA(100): 1.99     MA(250): 4.72
MACD: MACD(12,26): 0.01     Signal(9):
Stochastic oscillator: %K(14,3): 70.27     %D(3): 66.55
RSI: RSI(14): 50.81
52-week: High: 11.40  Low: 1.10  Change(%): -81.4
Average Vol(K): 3-Month: 25844  10-Days: 15404

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
VLRX has closed above bottom band by 46.7%. Bollinger Bands are 77.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to VLRX's normal range. The bands have been in this narrow range for 57 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Valeritas Rallies On Positive Preclinical Data For CBD Delivery Using Wearable Device
Valeritas Holdings Inc (NASDAQ: VLRX ) shares have shed more than 61% in the year-to-date period. The stock is picking up some momentum Tuesday following a pre-clinical data readout from the medical technology company. What Happened Valeritas, which makes the V-Go – Wearable Insulin Delivery Device using its proprietary h-Patch technology, announced positive results from a preclinical pharmacokinetic study of cannabidiol subcutaneous infusion with two dosing regimens delivered using its proprietary h-Patch wearable drug delivery device. The study evaluated CBD delivered over a single 24-hour period using the h-Patch, with two doses: 40mg/24 hour and 76mg/24 hour tested using the patch. The pharmacokinetics … Full story available on

Valeritas Insulin Device For Diabetics Accepted Under Managed Formulary
Valeritas Holdings (NASDAQ: VLRX ) shares are trading higher after the company on Tuesday afternoon announced its V-Go wearable insulin device has been adopted on multiple managed care formularies. The V-Go is a disposable device for the delivery of … Full story available on

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Medical Instruments Supplies
Shares Out. (M) 8.33
Shares Float (M) 6.29
% Held by Insiders 0.41
% Held by Institutions 71.12
Shares Short (K) 575
Shares Short P. Month (K)

Stock Financials

EPS -10.721
Book Value (p.s.) 1.330
PEG Ratio
Profit Margin -183.82
Operating Margin -170.55
Return on Assets (ttm) -66.5
Return on Equity (ttm) -2955.8
Qtrly Rev. Growth 22.2
Gross Profit (p.s.) 1.491
Sales Per Share
EBITDA (p.s.) -5.846
Qtrly Earnings Growth
Operating Cash Flow (M) -43.27
Levered Free Cash Flow (M) -26.98

Stock Valuations

P/E -0.14
P/E Growth Ratio -0.01
P/BV 1.11
P/S 0.26
P/CF -0.28

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-05-20
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.